A citation-based method for searching scientific literature

R A Roos, M Vegter-van der Vlis, J Hermans, H M Elshove, A C Moll, J J van de Kamp, G W Bruyn. J Med Genet 1991
Times Cited: 80







List of co-cited articles
667 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
345
30


A polymorphic DNA marker genetically linked to Huntington's disease.
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
28


On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
95
26

Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
83
26

Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention.
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
74
25


The measurement of pessimism: the hopelessness scale.
A T Beck, A Weissman, D Lester, L Trexler. J Consult Clin Psychol 1974
22

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
22

Testing for Huntington's disease with support for all parties.
A Tibben, M Vegter-vd Vlis, M F vd Niermeijer, J J Kamp, R A Roos, H G Rooijmans, P G Frets, F Verhage. Lancet 1990
41
43

Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
59
28

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.
J D Brook, M E McCurrach, H G Harley, A J Buckler, D Church, H Aburatani, K Hunter, V P Stanton, J P Thirion, T Hudson. Cell 1992
21


DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects.
A Tibben, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks. Am J Med Genet 1992
74
21

Predictive testing for Huntington's disease with use of a linked DNA marker.
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
154
20





Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy.
J Buxton, P Shelbourne, J Davies, C Jones, T Van Tongeren, C Aslanidis, P de Jong, G Jansen, M Anvret, B Riley. Nature 1992
569
18


Paradox of a better test for Huntington's disease.
A Maat-Kievit, M Vegter-van der Vlis, M Zoeteweij, M Losekoot, A van Haeringen, R Roos. J Neurol Neurosurg Psychiatry 2000
61
24

Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
103
18

Differences in duration of Huntington's disease based on age at onset.
T Foroud, J Gray, J Ivashina, P M Conneally. J Neurol Neurosurg Psychiatry 1999
129
18

Validity and uses of a screening questionnaire (GHQ) in the community.
A Tarnopolsky, D J Hand, E K McLean, H Roberts, R D Wiggins. Br J Psychiatry 1979
166
17

Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
103
17


Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
69
20




Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy.
C Tsilfidis, A E MacKenzie, G Mettler, J Barceló, R G Korneluk. Nat Genet 1992
319
16

Sex differences in a transgenic rat model of Huntington's disease: decreased 17beta-estradiol levels correlate with reduced numbers of DARPP32+ neurons in males.
Felix J Bode, Michael Stephan, Hendrik Suhling, Reinhard Pabst, Rainer H Straub, Kerstin A Raber, Michael Bonin, Huu Phuc Nguyen, Olaf Riess, Andreas Bauer,[...]. Hum Mol Genet 2008
86
16

Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
181
15


ICF syndrome: a new case and review of the literature.
D F Smeets, U Moog, C M Weemaes, G Vaes-Peeters, G F Merkx, J P Niehof, G Hamers. Hum Genet 1994
88
15


Non-participation in predictive testing for Huntington's disease: individual decision-making, personality and avoidant behaviour in the family.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, T Cloostermans, J J Cassiman, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Eur J Hum Genet 1997
52
23


Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.
M E Brunkow, E W Jeffery, K A Hjerrild, B Paeper, L B Clark, S A Yasayko, J E Wilkinson, D Galas, S F Ziegler, F Ramsdell. Nat Genet 2001
15


A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathy.
N Satake, M Nakanishi, M Okano, K Tomizawa, A Ishizaka, K Kojima, M Onodera, T Ariga, A Satake, Y Sakiyama. Eur J Pediatr 1993
65
18

Unstable DNA sequence in myotonic dystrophy.
H G Harley, S A Rundle, W Reardon, J Myring, S Crow, J D Brook, P S Harper, D J Shaw. Lancet 1992
181
15

Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene.
G L Xu, T H Bestor, D Bourc'his, C L Hsieh, N Tommerup, M Bugge, M Hulten, X Qu, J J Russo, E Viegas-Péquignot. Nature 1999
823
15

Maternal uniparental disomy of chromosome 1 with no apparent phenotypic effects.
L L Field, R Tobias, W P Robinson, R Paisey, S Bain. Am J Hum Genet 1998
45
26

Functional heterogeneity of C-terminal peroxisome targeting signal 1 in PEX5-defective patients.
N Shimozawa, Z Zhang, Y Suzuki, A Imamura, T Tsukamoto, T Osumi, Y Fujiki, T Orii, P G Barth, R J Wanders,[...]. Biochem Biophys Res Commun 1999
46
26

Chediak-Higashi syndrome associated with maternal uniparental isodisomy of chromosome 1.
R Dufourcq-Lagelouse, N Lambert, M Duval, G Viot, E Vilmer, A Fischer, M Prieur, G de Saint Basile. Eur J Hum Genet 1999
49
24

Sponastrime dysplasia. A radiologic-pathologic correlation.
R S Lachman, H Stoss, J Spranger. Pediatr Radiol 1989
28
42



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.